Suppr超能文献

疫苗策略:优化结果。

Vaccine strategies: Optimising outcomes.

作者信息

Hardt Karin, Bonanni Paolo, King Susan, Santos Jose Ignacio, El-Hodhod Mostafa, Zimet Gregory D, Preiss Scott

机构信息

GSK Vaccines, Avenue Fleming 20, Parc de la Noire Epine, B-1300 Wavre, Belgium.

University of Florence, Department of Health Sciences, Viale GB Morgagni 48, Florence, Italy.

出版信息

Vaccine. 2016 Dec 20;34(52):6691-6699. doi: 10.1016/j.vaccine.2016.10.078. Epub 2016 Nov 23.

Abstract

Successful immunisation programmes generally result from high vaccine effectiveness and adequate uptake of vaccines. In the development of new vaccination strategies, the structure and strength of the local healthcare system is a key consideration. In high income countries, existing infrastructures are usually used, while in less developed countries, the capacity for introducing new vaccines may need to be strengthened, particularly for vaccines administered beyond early childhood, such as the measles or human papillomavirus (HPV) vaccine. Reliable immunisation service funding is another important factor and low income countries often need external supplementary sources of finance. Many regions also obtain support in generating an evidence base for vaccination via initiatives created by organisations including World Health Organization (WHO), the Pan American Health Organization (PAHO), the Agence de Médecine Préventive and the Sabin Vaccine Institute. Strong monitoring and surveillance mechanisms are also required. An example is the efficient and low-cost approaches for measuring the impact of the hepatitis B control initiative and evaluating achievement of goals that have been established in the WHO Western Pacific region. A review of implementation strategies reveals differing degrees of success. For example, in the Americas, PAHO advanced a measles-mumps-rubella vaccine strategy, targeting different population groups in mass, catch-up and follow-up vaccination campaigns. This has had much success but coverage data from some parts of the region suggest that children are still not receiving all appropriate vaccines, highlighting problems with local service infrastructures. Stark differences in coverage levels are also observed among high income countries, as is the case with HPV vaccine implementation in the USA versus the UK and Australia, reflecting differences in delivery settings. Experience and research have shown which vaccine strategies work well and the factors that encourage success, which often include strong support from government and healthcare organisations, as well as tailored, culturally-appropriate local approaches to optimise outcomes.

摘要

成功的免疫规划通常源于高疫苗效力和疫苗的充分接种。在制定新的疫苗接种策略时,当地医疗保健系统的结构和实力是关键考虑因素。在高收入国家,通常利用现有的基础设施,而在欠发达国家,可能需要加强引入新疫苗的能力,特别是对于幼儿期之后接种的疫苗,如麻疹或人乳头瘤病毒(HPV)疫苗。可靠的免疫服务资金是另一个重要因素,低收入国家往往需要外部补充资金来源。许多地区还通过世界卫生组织(WHO)、泛美卫生组织(PAHO)、预防医学机构和赛宾疫苗研究所等组织发起的倡议,在为疫苗接种建立证据基础方面获得支持。还需要强有力的监测和监督机制。例如,世卫组织西太平洋区域采用了高效且低成本的方法来衡量乙肝控制倡议的影响并评估既定目标的实现情况。对实施策略的审查显示出不同程度的成功。例如,在美洲,泛美卫生组织推进了麻疹 - 腮腺炎 - 风疹疫苗策略,在大规模、补种和后续疫苗接种活动中针对不同人群。这取得了很大成功,但该地区一些地方的覆盖率数据表明,儿童仍未接种所有适当的疫苗,凸显了当地服务基础设施存在的问题。在高收入国家之间也观察到覆盖率水平存在明显差异,美国与英国和澳大利亚在HPV疫苗实施方面的情况就是如此,这反映了接种环境的差异。经验和研究表明了哪些疫苗策略效果良好以及促成成功的因素,这些因素通常包括政府和医疗保健组织的大力支持,以及为优化结果而量身定制的、符合当地文化的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验